Detalles de la búsqueda
1.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
N Engl J Med;
379(2): 122-137, 2018 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863451
2.
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Breast Cancer Res Treat;
181(2): 347-359, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274665
3.
Adjuvant ovarian suppression in premenopausal breast cancer.
N Engl J Med;
372(5): 436-46, 2015 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25495490
4.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med;
371(2): 107-18, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24881463
5.
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Breast Cancer Res;
18(1): 110, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825388
6.
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol;
16(7): 848-58, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26092816
7.
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Breast Cancer Res Treat;
154(2): 275-86, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493064
8.
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
J Clin Oncol;
41(7): 1376-1382, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521078
9.
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
J Clin Oncol;
41(7): 1370-1375, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493334
10.
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
J Clin Oncol;
38(12): 1293-1303, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618131
11.
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
J Clin Oncol;
35(27): 3113-3122, 2017 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28654365
12.
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.
J Clin Oncol;
34(19): 2221-31, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27044936
13.
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.
Breast;
22(6): 1094-100, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24095609
Resultados
1 -
13
de 13
1
Próxima >
>>